Skip to main content
. 2019 Jul 27;7(1):84–92. doi: 10.1016/j.gendis.2019.07.010

Figure 2.

Figure 2

Dihydrorhodamine test by flow cytometry showing oxidative capacity of the PMA-stimulated neutrophils (green). (A) Control sample depicting normal shift of the activated neutrophils with the median fluorescence intensity (MFI) of 277.95 compared to 2.75 in the unstimulated neutrophils (red). (B) DHR of a patient with a defect in CYBB showing absent shift of the stimulated neutrophils (green) with MFI of 2.57 compared to 2.02 in the control (red). (C) DHR of an X-linked carrier of CYBB defect showing a bimodal population of the stimulated neutrophils (green).